UCLA Radiation Oncology at ASTRO 2025 - Flipbook - Page 9
TUESDAY, SEPTEMBER 30, 2025
Tuesday, September 30 at 2:30PM
SESSION: PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care /
3385 3 Influence of Pancreatic Ductal Adenocarcinoma Anatomic Tumor Subregion
on Oncologic Outcomes Following MRI-Guided Stereotactic Body Radiotherapy
PRESENTER: ROJINE ARIANI, MD, MS
LOCATION: Hall F
Tuesday, September 30 at 2:30PM
SESSION: PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care /
3413 3 Association of Central Hepatobiliary Tract Radiation Dose and Hepatobiliary
Outcomes After MRI-Guided Liver Stereotactic Body Radiotherapy
PRESENTER: TRAVIS COURTNEY, MD, MAS
LOCATION: Hall F
Tuesday, September 30 at 4:00PM
SESSION: PQA 09 3 Hematologic Malignancies, Digital Health Innovation and
Informatics / 3653 Emergency Department Visits and Hospital Admissions Among
Patients Undergoing Radiation Therapy: A Large-Scale Informatics Analysis By
Disease Site
PRESENTER: MIRIAM LANE, MD
LOCATION: Hall F
Tuesday, September 30 at 4:00PM
SESSION: PQA 09 - Hematologic Malignancies, Digital Health Innovation and
Informatics / 3689 3 Expert Evaluation of Patient-Oriented AI-Generated Responses
Regarding Radiotherapy for Nonmalignant Indications
PRESENTER: NICOLAS NELSON. MD
LOCATION: Hall F
Tuesday, September 30 at 4:00PM
PQA 09 - Hematologic Malignancies, Digital Health Innovation, and Informatics /
3744 3 Radiation Oncology Drug Prescription Patterns in Medicare Part D
PRESENTER: TAMIA WILLIAMS, BS
LOCATION: Hall F
